Atviri finansavimo kvietimai

Terminas: 2027-09-15InnovationProcurement

Reinforcing synergies between experimentation spaces and innovation procurement

Expected Outcome:Project results are expected to contribute to the following outcomes:Advancing public sector modernization by capitalising on the transformational power of innovative technologies to improve the quality and efficiency of public services;Reinforce EU strategic autonomy and increase resilience in the supply chains by opening up opportunities for innovative companies, including notably SMEs and startups, to access the public procurement market and scale up their business;Improving opportunities for market uptake and economies of scale for the supply side through increased demand for innovative solutions and where relevant contribution to standardisation, regulation or certification;It is expected that if PCP results in the successful innovative solutions than at least one of those will be ready for deployment or even being already deployed in the project.Supporting the uptake of innovative and sustainable solutions through collaborative procurement approaches that encourage safer and more efficient practices in public sector applications. Scope:This topic aims to shorten the time to market for innovations by reinforcing synergies between innovation procurement and experimentation spaces such as test beds, livings labs or regulatory sandboxes. While public buyers often do not use experimentation spaces to test before they invest, companies also too often only start looking for potential customers, verifying regulatory compliance and product certification after R&

Enhancing the involvement of philanthropic organisations in innovation ecosystems

Expected Outcome:Project results are expected to contribute to the following outcomes:Increase the collaboration of philanthropic organisations with higher education institutions, TTOs, innovative companies and Venture Capital (VCs) in supporting innovative projects and companies to develop and grow;Support the transition of academic research and innovations from higher education institutions to market-ready solutions. Scope:There are currently more than 33000 philanthropic organisations in Europe with EUR 50 billion of annual philanthropic expenditure and EUR 567 billion pool of philanthropic assets[1]. Philanthropic organisations and higher education institutions have been working together for many years in supporting the development of breakthrough research and technologies. At the same time, the EU still faces challenges in bringing technologies to the market. Therefore, this action aims at building on these established models of cooperation to support the transfer of developed technologies to the market by supporting facilities (like living labs and test beds) and/or engaging relevant stakeholders to further commercialize technologies with concrete common objective.The purpose of this topic is to incentivise philanthropic organisations support to projects with high-potential, not only through financial resources, but also by providing access to expertise and networks of like-minded stakeholders and investors, as well as by being themselves first users of new technologies

Secure PQC implementations, Cryptanalysis and Post-quantum Digital Trust

Expected Outcome:Proposals are expected to contribute one or more of the following:Practical robust implementations of PQC schemes that can withstand implementation attacks including side-channel attacks, fault attacks and combined attacks, and design of automated tools for evaluating the security of PQC implementations. Comprehensive guidelines for implementing countermeasures against a wide range of attacks;Advances in understanding the quantum hardness of mathematical problem classes; new quantum algorithms and improvements in quantum programming and implementation; security validation methods; design of post-quantum schemes with improved security against quantum and AI-based attacks;Post-quantum schemes and protocols to support privacy-friendly applications and services, ncluding the secure and private use of electronic identities. Design of new digital signatures, key encapsulation mechanisms, and other schemes or use of existing ones to build new verification protocols. Scope:Securing PQC algorithm implementations is vital to protect against implementation attacks, such as side channel attacks, fault attacks and combinations of these, which may be amplified by deep learning. Current countermeasures incur significant overhead, and new approaches are needed to balance security and performance. Formal verification tools and methodologies can help achieve this goal and provide machine-readable evidence. Furthermore, to boost confidence in PQC systems, their security should

New primitives and protocols for functionalities of future hybrid classical-hybrid and quantum networks

Expected Outcome:Proposals are expected to contribute to one or more of the following:New primitives beyond Quantum Key Distribution (QKD) for future hybrid classical-quantum and quantum networks either as quantum equivalents of classical primitives or as new primitives for new practical applications, also in the relativistic setting when relevant, or as new primitives and protocols with modular, realistic integration of solutions from different cryptographic approaches, with focus on beyond-QKD applications and with gradual release on trust in hardware;Analysis of the applicability and strength of the results compared to their best classical-only counterpart, critical analysis of the formal assumptions and of performance, security proofs;Investigation of fundamental aspects of quantum information processing tasks, their eventual limits; and/or the connection between quantum computing and cryptography for insights for stronger cryptographic foundations;Roadmap for quantum cryptography and networks functionalities. Scope:The action supports research on new primitives and protocols beyond QKD for security and trust-based applications, by combining different cryptographic approaches and by exploiting insights from quantum information science, to demonstrate compelling quases of quantum cryptographic advantage and obtain foundational results on the unique features of quantum protocols. The goal is to build on the basis of insights from the field of real-world, applied cryptograph

Secure Computing Continuum (IoT, Edge, Cloud, Data spaces)

Expected Outcome:Proposals are expected to contribute to one or more of the following:Enhanced resilience against distributed cyber threats and adversarial attacks targeting interconnected systems, while preserving data privacy in highly dynamic and heterogeneous environments;Security solutions tailored to distributed computing systems including for example IoT and edge computing environments, integrating privacy-preserving mechanisms;Improved interoperability of security measures and cross-layer security, including the compatibility of privacy-enhancing technologies across different layers of the computing continuum and data spaces, and across providers in the multi-provider edge cloud continuum. Scope:This topic aims to advance security across the entire computing continuum, spanning IoT devices, edge computing, cloud infrastructures, AI computing environments, and data spaces. Proposals should address critical challenges such as ensuring data integrity in highly distributed and dynamic environments, implementing robust zero-trust architectures to secure interconnected and heterogeneous systems, and enabling comprehensive protection for sensitive data and processes. Privacy should be considered a core element of these approaches, ensuring that data confidentiality is preserved throughout its lifecycle, in compliance with relevant data protection frameworks, such as GDPR. Solutions are expected to deliver tangible and measurable security improvements across all layers of the

Artificial Intelligence for Cybersecurity applications

Expected Outcome:Proposals are expected to contribute to one or more of the following:AI-driven solutions for real-time cyber threat detection;Advanced adaptive AI systems that evolve with dynamic cybersecurity challenges;Contribute to drastically reduce reaction time for the recovery of systems. Scope:Artificial Intelligence is increasingly utilised in cybersecurity for threat detection, incident response, and adaptive defence mechanisms. However, AI-driven systems themselves are susceptible to adversarial manipulation and bias. This topic aims to advance AI-based cybersecurity applications while ensuring that AI-driven solutions remain resilient, transparent, and compliant with regulatory frameworks such as the AI Act. In this context, the topic explores the role of all types of AI, including generative AI, in cybersecurity applications, including automated threat detection, adaptive cyber defence, and AI-driven cyber threat intelligence. Proposals should develop solutions for trustworthy AI in cybersecurity contexts including addressing adversarial AI risks, in compliance with the provisions of the AI Act. The topic is expected to:Develop AI-driven solutions and tools for real-time cyber threat detection. Investigating novel machine learning techniques to detect anomalies, malicious activity, and AI-powered cyber threats in real time, improving situational awareness and response times.Develop adaptive AI systems capable of evolving with dynamic cybersecurity challenges. Ex

Terminas: 2027-09-15DigitalAgenda

Reducing soil sealing through sustainable urban and territorial design in the New European Bauhaus

Expected Outcome:Projects results are expected to contribute to all of the following expected outcomes:Increased number of innovative and regenerative[1] planning and spatial design solutions that apply the New European Bauhaus (NEB) principles of sustainability, aesthetics[2], and inclusivity[1] to reduce soil sealing and land take, improve soil health, support food systems transformation, and strengthen climate resilience and biodiversity are available.Increased adoption, upscaling and market uptake of these solutions across diverse territorial contexts (urban, peri-urban, and rural) to enhance soil health, and benefit local communities.Effective funding models and enabling policy frameworks to support territorial transformation. Scope:Reducing soil sealing and land take is a critical challenge for climate and water resilience, ecosystem health, biodiversity, food systems transformation, and the livability of human settlements. As urbanisation and infrastructure development expand across Europe’s urban, peri-urban, and rural areas, healthy soils are increasingly sealed, contributing to the loss of vital ecosystem services and biodiversity and increased vulnerability to climate change impacts. Despite growing awareness, there is a lack of integrated and scalable solutions to address these challenges through spatial design and planning. There is a pressing need for solutions that apply the New European Bauhaus (NEB) principles of sustainability, aesthetics, and inclusivity to

Terminas: 2027-09-15DigitalAgenda

Startup Europe

Expected Outcome:Project results are expected to contribute to the following outcomes:Increasing the market footprint of European startups in strategic digital technologies and deep tech[1] innovation, including but not limited to Artificial Intelligence, Advanced Computing, Cybersecurity, Next Generation Internet, Blockchain, Internet of Things, Metaverse, Energy, Greentech, AgriTech, and Fintech;Better connection of startups and scaleups, including European Institute of Innovation and Technology (EIT) and European Innovation Council (EIC)-supported startups and Seal of Excellence holders, to relevant local and/or European ecosystems, communities, and potential new markets;A scaling up of capabilities in matching technology solutions developed by highly innovative European Union (EU)-funded digital and deep tech startups with investment and growth opportunities in collaboration with other initiatives such as: the EIC, the EIT and the Knowledge and Innovation Communities (KICs), InvestEU, the Digital Europe Programme, Women TechEU, public and private buyers, or investors and corporate innovation ventures. In pursuit of the above outcomes the projects are expected to prioritise:Startups and scaleups that have already achieved market-product fit or scale ups that have raised at least a round of financing (seed or later); andStartups and scaleups established in ‘moderate’ or ‘emerging’ innovator countries and/or regions; orWomen-led startups and scaleups[2]. Scope:This action wi

Improving equitable health outcomes and added value for and with cancer patients through health-economics research, health systems research and outcomes research

Expected Outcome:Proposals under this topic should aim to deliver results that are directed and tailored towards, and contribute to all of the following expected outcomes:People at risk of cancer, cancer patients and their caregivers/families benefit from access to more effective and cost-effective, national or regional, cancer control programmes across EU Member States and Associated Countries.Researchers, physicians, innovators[1], SMEs and other professionals from different disciplines and sectors have access to national, regional or local data on healthcare spending (such as expenditures, resource allocations, organisation and type of healthcare interventions, and for which cancer indications, infrastructure, medical prescriptions, drug pricing, drug sales, reimbursement data from health insurers, population-based cancer registries or other cancer-centred registry data, longitudinal epidemiology data) for research and commercial purposes.National or regional healthcare systems, healthcare providers, policymakers and authorities in European regions, EU Member States and Associated Countries have the evidence to improve equitable health outcomes of cancer patients by addressing direct and indirect costs, delivering value-driven cancer care and tackling organisational challenges of a rapidly-changing, dynamic cancer control[2] landscape. Scope:Proposals should address all of the following:Establish, validate or further refine health-economics research, health systems researc

Clinical research by Comprehensive Cancer Infrastructures for the benefit of patients with common cancers

Expected Outcome:Proposals under this topic should aim to deliver results that are directed and tailored towards, and contribute to all of the following expected outcomes:Patients afflicted by lung, bowel, breast or prostate cancer[1], will benefit from the outcomes of evidence-based, tailored, innovative, affordable and accessible diagnosis- and treatment-centred clinical research programmes by comprehensive cancer infrastructures[2].Researchers, physicians, patient representatives, civil society, charities, foundations, insurance companies, SMEs and innovators[3] will seize opportunities to respectively co-create, support, upscale or commercialise outcomes of evidence-based, tailored, affordable and accessible clinical research programmes for the diagnosis and treatment of patients afflicted by lung, bowel, breast or prostate cancer.National and regional healthcare providers, healthcare payers, policymakers and authorities in European regions, EU Member States and Associated Countries have the evidence to engage in piloting, upscaling or implementing appropriate clinical research programmes for the diagnosis and treatment of patients afflicted by lung, bowel, breast or prostate cancer.Scope:Lung, bowel, breast and prostate cancer incidence, mortality and prevalence across EU Member States and Associated Countries are increasing while showing substantial variation, with Central and Eastern European communities, regions and countries particularly affected[4]. At the same time

Phase 1 including first-in-human clinical trials to test biomarker-guided medicines or multi-modal treatment interventions for patients with rare or very rare cancers or cancer subtypes

Expected Outcome:Proposals under this topic should aim to deliver results that are directed and tailored towards, and contribute to all of the following expected outcomes:Patients with rare or very rare cancers or cancer subtypes have access to tailored, promising biomarker-guided medicines or multi-modal treatment interventions via participation in subsequent clinical trials or national or regional compassionate use programmes by health authorities;Researchers, physicians, innovators[1], startup, spin-off and spin-out companies, SMEs, charities or foundations and other professionals from different disciplines and sectors have access to innovative technology, medical devices or promising biomarker-guided medicines for further validation or commercialisation;National healthcare providers, policymakers and authorities in European regions, EU Member States and Associated Countries have early safety and efficacy evidence to support further testing of affordable biomarker-guided medicines or multi-modal treatment interventions that benefit patients with rare or very rare cancers in their healthcare systems; Scope:Patients with rare and very rare[2] cancers across EU Member States and Associated Countries often present with advanced disease due to late diagnosis and have access to few treatment options. Hence, these patients typically have a lower 5-year overall survival than those with more common cancers and face challenges with timely access to a small number of appropriate phas

Pre-commercial procurement of affordable solutions for healthcare systems in the areas of cancer technologies, cancer medical devices, or cancer medicines

Expected Outcome:This action supports the follow-up to the July 2023 Communication on EU Missions assessment[1]. Proposals under this topic should aim to deliver results that are directed and tailored towards, and contribute to all of the following expected outcomes:Public procurers, possibly in cooperation with private ones, in the area of cancer-centred healthcare stimulate the competitive development of market-ready, affordable, innovative solutions.The chosen solutions take into consideration the needs of cancer patients living with and beyond cancer through research that supports end-user engagement using participative research models.Procurers create opportunities for European health, technology and medical devices, industrial actors (including start-ups, spin-offs, spin-outs, scale-ups, SMEs) to bring to the market affordable innovations that are cost-efficient, safe and have demonstrated improved health outcomes for cancer patients living with and beyond cancer.Procurers facilitate the commercialisation of innovative solutions for and with cancer patients by their successful suppliers through providing them with first customer references for the validation and first pilot deployment.Policymakers, healthcare providers and professionals, cancer patients and their carers – each in their respective areas – exchange and adopt good practices and the best treatment, technology and medical device solutions that the market can deliver through participative research. Scope:Pre-

Support a Young Cancer Survivor Quality of Life (QoL) research programme by cancer charities and funding agencies

Expected Outcome:This action supports the follow-up to the July 2023 Communication on EU Missions assessment[1]. The successful proposal under this topic should aim to deliver results that are directed and tailored towards and contribute to all of the following expected outcomes:Together, a network of registered cancer charities and funding agencies support transnational research and innovation projects on quality of life of children (age range 0-14, age at time of first diagnosis), adolescents (age range 15-19, age at time of first diagnosis) and young adults (age range 20-39, age at time of first diagnosis), cancer patients and survivors using their own financial resources.Projects supported by the network of charities and funding agencies will boost quality of life and long-term outcomes for young cancer patients and survivors, including improved physical, emotional, and social well-being.Researchers, innovators, and professionals from different disciplines and sectors ensure accessibility and re-usability of relevant digital data, to support the future UNCAN.eu research data platform, which is currently in preparation. Scope:Due to significant investments in research and innovation, cancer survival rates in Europe have soared, with more than 12 million survivors, including 500,000 childhood cancer survivors. However, survivors, their families, and caregivers continue to face numerous challenges. Young cancer survivors, in particular, frequently suffer from long-term effec

Leveraging functional genomics to reveal novel targets for cancer treatment

Expected Outcome:Proposals under this topic should aim to deliver results that are directed and tailored towards and contribute to all of the following expected outcomes:Researchers and health professionals gain a deeper understanding of the functional effects of tumour heterogeneity during cancer initiation and progression, supporting the identification of more precise and novel therapeutic targets. Researchers, health professionals and innovators benefit from improved knowledge and tools to support the discovery and development of next generation genomically-informed cancer treatments.Researchers, innovators, and professionals across disciplines and sectors contribute to the UNCAN.eu research data platform by ensuring data interoperability, and enabling sustainable access to newly developed digital tools and models for the analysis and management of multimodal clinical data. Scope:The proposed topic will contribute to the EU Cancer Mission objective of improving the understanding of cancer initiation and progression. Of particular interest for this topic are paediatric and adolescent cancers[1] , cancers with limited treatment options, refractory cancers, rare cancers or cancer types with low five-year survival rates. Proposals may include the design of exploratory mechanistic studies using longitudinal patient bio-samples, clinical proof-of-concept studies and/or observational and translational studies involving newly collected or existing data, as appropriate. Applicants

Virtual Human Twins (VHTs) for integrated clinical decision support in prevention and diagnosis

Expected Outcome:This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Developing and using new tools, technologies and digital solutions for a healthy society”. To that end, proposals under this topic should aim to deliver results that are directed at, tailored towards and contributing to all the following expected outcomes:Healthcare professionals have access to multi-scale[1], multi-organ models of individual patients that aim to improve prevention and diagnosis in high disease burden areas.Health professionals benefit from enhanced knowledge of complex diseases and co-morbidities by recourse to multi-scale, multi-organ models.Patients with diverse characteristics (e.g. of any sex, age group, racial or ethnic origin[2]) benefit from improved, integrated and personalised prevention and diagnostics tools.Health professionals and patients benefit from the use of “Virtual Human Twin” (VHT) models which enable integration of other preventive and diagnostic tools and modalities. Scope:VHTs are digital representations and in-silico models of an individual’s health and disease state at different levels of anatomy. Multi-scale, multi-organ VHT solutions have a potential for tailored prevention and diagnosis, particularly in areas of high disease burden, and can significantly benefit citizens' health and the efficiency of EU health systems.Proposals should take into account the work of projects funded under topi

Towards the next generation of frontier Artificial Intelligence models for healthcare

Expected Outcome:This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Developing and using new tools, technologies and digital solutions for a healthy society”. To that end, proposals under this topic should aim to deliver results that are directed at, tailored towards and contributing to all the following expected outcomes:Researchers and innovators benefit from an improved understanding of how to develop and use the next generation of frontier Artificial Intelligence (AI) models for healthcare, including how to leverage AI Factories and how to combine and expand the capabilities of existing foundation models towards inclusive and personalised medicine.Researchers and innovators benefit from an improved understanding of how to leverage highly heterogeneous and multimodal health data spanning a range of anatomical scales (i.e. the micro to the macro level).Multidisciplinary stakeholders have access to a collaboratively created roadmap for developing the next generation of frontier AI models for healthcare. Scope:The AI Continent Action Plan[1] identifies the health sector, encompassing life sciences, medical devices and healthcare delivery, as one of the key strategic sectors. The action will contribute to making European life sciences[2] and healthcare more impactful and productive by fostering the full integration of advanced AI in the health sector and biomedical research, along the objectives of the

Advancing bio-printing of living cells for regenerative medicine

Expected Outcome:This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Developing and using new tools, technologies and digital solutions for a healthy society”. To that end, proposals under this topic should aim to deliver results that are directed at, tailored towards and contributing to most of the following expected outcomes:Biomedical scientists from academia and industry will gain access to entire bio-printing units designed to regenerate human tissue.Healthcare professionals acquire information on the safe and effective use of equipment enabling advanced therapies with bio-printed human tissue.Healthcare providers dispose of tools enabling them to treat conditions of unmet medical need.Individual patients will benefit from a personalised approach to their respective medical condition thanks to the bio-printed regenerative medicine solution. Scope:Tissue-specific functional 3D bio-printing of living cells has made significant progress as a new approach for transplantation applications in regenerative medicine. There are currently several types of bio-printing technologies under development for the repair of different targeted tissues or organs. To fully unleash the potential of bio-printed cell constructs for regenerative medicine several bottlenecks still need to be overcome. Various studies in pre-clinical models have shown that bio-printed cell constructs or tissues hold great promise for regener

Terminas: 2027-09-16AI

Terminas: 2027-09-16OCEAN

Advancing interdisciplinary, data-driven research at the biodiversity- health interface under a One Health approach

Expected Outcome:Proposals are expected to contribute to all the following expected outcomes:public authorities, researchers and policymakers have access to robust knowledge foundations and analytical frameworks that enable inter- and transdisciplinary biodiversity-related research and collaboration, address interdependencies and strengthen the operationalisation of the One Health and Planetary Health approaches;researchers, public authorities and global organisations have access to Findable Accessible Interoperable and Reusable (FAIR) data[1] supported by enhanced digital infrastructures. These data will build on improved identification, mobilisation and interoperability of existing data across thematic areas relevant to ecosystem and wildlife health, the main drivers of biodiversity loss and their impacts on human and animal health;researchers, affected communities, food producers, data scientists, public authorities, healthcare professionals and animal health professionals, policymakers, risk assessors civil society organisations, private sector actors, societal partners and other stakeholders can assess the health benefits and risk prevention associated with maintaining, improving and restoring ecosystem health. These stakeholders will also be supported in applying evidence-based and tested recommendations, tools and solutions to effectively mainstream biodiversity in the operationalisation of One Health and Planetary Health approaches through biodiversity conservation an

Terminas: 2027-09-21MultiActorApproach

Living labs to monitor and mitigate carcinogenic substances in and originating from soils: Evaluating their effects on human cancer risks

Expected Outcome:Activities under this topic will directly progress towards the goal of the Mission Soil to set up 100 living labs and lighthouses to lead the transition to healthy soils by 2030. Activities will also contribute to the goal of the Cancer Mission, i.e.: ‘to improve the lives of more than 3 million people by 2030, through prevention, cure and for those affected by cancer including their families, to live longer and better’. Activities should also contribute to meeting the European Green Deal ambitions and targets and more specifically those of the EU Biodiversity Strategy for 2030, the EU Soil Strategy for 2030, the proposal for a Soil Monitoring and Resilience Directive, the Zero Pollution Action Plan, the Europe's Beating Cancer Plan, the One Health approach, the European Health Data Space, the Chemicals Strategy for Sustainability, the European Chemicals Industry Action Plan, as well as to the Sustainable Development Goals[1].Project results are expected to contribute to all the following expected outcomes:increased capacities for participatory, interdisciplinary and transdisciplinary research and innovation to co-create, and co-implement economically viable soil health solutions tailored to soils contaminated with or at risk of contamination by carcinogenic substances;enhanced understanding of the environmental pathways through which these substances affect humans and the food chain, and the links (drivers and processes) between carcinogenic substances[2] in

Terminas: 2027-09-21MultiActorApproach

Demonstrating transformative solutions to increase cross-border climate resilience

Expected Outcome:In support to the implementation of the EU Adaptation Strategy, the EU Mission on Adaptation to Climate Change and the EU Preparedness Union Strategy and contributing to the upcoming European Climate Action Plan, project results are expected to improve adaptative capacities of European internal border regional and local authorities, allowing them to jointly address with their neighbours the pressing climate risks.Projects results should contribute to all of the following outcomes:Climate resilience solutions for cross-border risks have been developed and demonstrated. This includes social, governance or nature-based solutions.Regional and local authorities from each side of country borders are better prepared to withstand jointly the impacts of climate change, including systemic risks and cascading effects.National, regional and local authorities are taking on shared responsibilities and are actively involved in the development and testing of innovative solutions to deal with cross-border climate risks. Scope: Rationale Cross-border risks[1] and cooperation are crucial in the European Union, where 37.5% of the EU population lives in border areas, spanning 38 intra-EU borders that often involve both administrative and linguistic divides[2]. While adaptation plans are usually prepared within a single territory (e.g. at national, regional or local levels), climate risks do not stop at the borders. For instance, around 70% of Europe's freshwater bodies are part o

Terminas: 2027-09-21OCEAN

Green, circular and resilient harbours

Expected Outcome:This topic aims at directly engaging and supporting harbour/ports and their communities in demonstrating and accelerating the transitions needed for achieving one or several objectives of the Mission “Restore our Ocean and Waters”. The participation of relevant public bodies managing port authorities and their communities as partners of the consortium is strongly encouraged.Project results are expected to contribute to all of the following expected outcomes:Measurable, quantifiable, verifiable and ambitious progress towards reaching one or several interlinked objectives and targets of the Mission “Restore our Ocean and Waters by 2030”, as set out in the Mission Implementation Plan[1] through implementation of effective and well-managed place-based and people-centred actions;Involvement and increased readiness port cities and authorities for testing, deploying and upscaling systemic innovative solutions for restoring ecosystems and preventing their degradation, including by monitoring invasive species brought through maritime traffic or facilitating ecosystem connectivity;Increased number of port cities and authorities taking concrete measures to protect and restore marine and freshwater ecosystems and biodiversity, prevent and eliminate pollution of our ocean, seas and waters, and make the blue economy carbon-neutral and circular;Increased resilience of port/cities/authorities and their related communities to extreme climate events; sea-level rise and other e

Terminas: 2027-09-21OCEAN

Large-scale demonstration of protection, restoration and management of blue forest ecosystems in European sea basins

Expected Outcome:Project results are expected to contribute to all of the following expected outcomes:Increased area and improved condition of marine and coastal vegetated habitats within EU waters through effective on-site conservation, restoration and management of activities to help deliver on the objectives of the Nature Restoration Regulation;Maintained and enhanced capacity of blue carbon ecosystems to naturally store carbon, supporting EU climate mitigation goals;Enhanced capacity of marine vegetated habitats/blue carbon ecosystems to support biodiversity and fisheries;Established novel financing and incentive mechanisms that support conservation, restoration and management of blue forest ecosystems projects;Raised public awareness and improved community participation in blue forest ecosystems protection, restoration and management activities, ensuring long-term involvement. Scope:This topic seeks innovative multidisciplinary projects that will advance large-scale demonstration of protection, restoration and management of blue forest ecosystems, focusing on the assessment of ecological interactions, restoration of degraded ecosystems, conservation, and sustainable management within European sea basins. Projects are required to develop collaborations with EU Member States and Associated Countries national and regional agencies and authorities and policy makers and engage with local communities, researchers and NGOs. The direct involvement of relevant authorities and sta

Terminas: 2027-09-21OCEAN

Towards community-driven business models: coastal and freshwaters sustainable tourism

Expected Outcome:Project results are expected to contribute to all of the following expected outcomes:Innovative business models for the development of entrepreneurship and successful local community-driven marine, coastal and freshwater sustainable tourism initiatives;Scalable and economically viable initiatives with the potential to be replicated across multiple sea basins;Enhanced capacity-building and increased engagement of the coastal/river/lake communities and the private sector;Job creation and skills development;Improved marine, coastal and freshwater habitats, biodiversity and enhanced conservation capacity;Increased awareness and behavioural change of tourists and coastal communities towards the conservation of marine and freshwater ecosystems. Scope:The community-driven approach under this topic puts strong emphasis on engaging coastal, riparian and/or lakeside communities as well as relevant actors to build, in a sustainable way, local businesses that will support livelihood opportunities and stimulate investments, and will contribute to preserve and protect marine, coastal and freshwater habitats.Activities under this topic will contribute to the achievement of the Mission “Public mobilisation and engagement” actions by fostering community involvement, awareness and citizen participation to amplify impact, accelerating the uptake of community-led initiatives, anticipating and planning future investments for sustainable tourism. These activities should consider t